Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | PTPRA | P18433 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11670929 | 0.80 | KDM4E (0.61) | KDM4ESMN1; SMN2CHRM2DNM1MAOA | |
| Hydrochloric Acid SCHEMBL18115133 | 0.74 | LMNA (0.48) | KDM4EL3MBTL1LMNA | |
| Hydrochloric Acid SCHEMBL4112448 | 0.74 | LMNA (0.48) | KDM4EL3MBTL1LMNA | |
| Hydrochloric Acid SCHEMBL2253326 | 0.74 | LMNA (0.48) | KDM4EL3MBTL1LMNA | |
| Hydrochloric Acid SCHEMBL1199353 | 0.74 | LMNA (0.48) | KDM4EL3MBTL1LMNA | |
| SCHEMBL28730 | 0.74 | LMNA (0.52) | KDM4EL3MBTL1LMNA | |
| SCHEMBL2560773 | 0.74 | LMNA (0.52) | KDM4EL3MBTL1LMNA | |
| SCHEMBL5706423 | 0.74 | LMNA (0.52) | KDM4EL3MBTL1LMNA | |
| SCHEMBL3114813 | 0.74 | LMNA (0.52) | KDM4EL3MBTL1LMNA | |
| SCHEMBL22963142 | 0.74 | LMNA (0.52) | KDM4EL3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1797106-A1 | SYNTHESIS OF RADIOLABELED SUGAR METAL COMPLEXES | Triumf, operating as a joint venture by the Governors of the Universities of Alberta, (CA) | 2007-06-20 | — | — | EP | disclosed |
| WO-2006026855-A1 | SYNTHESIS OF RADIOLABELED SUGAR METAL COMPLEXES | TRIUMF, OPERATING AS A JOINT VENTURE BY THE GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE UNIVERSITY OF BRITISH COLUMBIA, CARLETON (CA) | 2006-03-16 | — | — | WO | disclosed |
| US-20060051291-A1 | Synthesis of radiolabeled sugar metal complexes | ADVANCED APPLIED PHYSICS SOLUTIONS, INC. (CA) | 2006-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060051291-A1 | Synthesis of radiolabeled sugar metal complexes | GFPT1, CSGALNACT1, TST | KDM4E 3069/4885SMN1; SMN2 4678/4885CHRM2 2781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.